|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.94 MXN | -2.83% |
|
-3.58% | -20.65% |
Chart calendar Genomma Lab Internacional, S.A.B. de C.V.
ed.IfHb2Zu-AaIRh12AHIVkTBAn4-lrOZguYKSyVBOzR2E.WIeRmsLHQOdo5DXNa_wSJ19PtIBdYPJoUeb_BkLgcAhvvfbrqdZz40XgGA~aca00779a641780353206644df957feb
Upcoming events on Genomma Lab Internacional, S.A.B. de C.V.
Past events on Genomma Lab Internacional, S.A.B. de C.V.
Past dividends on Genomma Lab Internacional, S.A.B. de C.V.
| 2025-06-29 | Interim Payment 0.2 MXN |
| 2025-03-12 | Interim Payment 0.2 MXN |
| 2024-12-16 | Interim Payment 0.2 MXN |
| 2024-09-12 | Interim Payment 0.2 MXN |
| 2024-06-19 | Interim Payment 0.2 MXN |
| 2024-03-20 | Interim Payment 0.19608 MXN |
| 2023-12-21 | Interim Payment 0.19608 MXN |
| 2023-09-26 | Interim Payment 0.19608 MXN |
| 2023-06-04 | Interim Payment 0.19608 MXN |
| 2022-11-08 | Interim Payment 0.381679 MXN |
| 2022-06-05 | Interim Payment 0.381679 MXN |
| 2021-12-07 | Interim Payment 0.381679 MXN |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million MXN | Released Forecast Spread | 16 859 17 084 -1.32% | 16 467 17 019 -3.24% | 18 607 18 433 0.95% | 19 471 | 20 724 | 22 438 |
|
EBITDA Million MXN | Released Forecast Spread | 3 471 3 581 -3.06% | 3 454 3 574 -3.38% | 4 330 4 189 3.37% | 4 655 | 4 984 | 5 451 |
|
EBIT Million MXN | Released Forecast Spread | 3 263 3 389 -3.72% | 3 224 3 378 -4.56% | 3 982 3 875 2.79% | 4 338 | 4 622 | 5 059 |
|
Earnings before Tax (EBT) Million MXN | Released Forecast Spread | 2 261 2 548 -11.24% | 1 685 1 980 -14.91% | 2 891 3 100 -6.74% | 3 835 | 4 239 | 4 888 |
|
Net income Million MXN | Released Forecast Spread | 1 397 1 679 -16.81% | 1 031 1 448 -28.8% | 2 137 2 135 0.09% | 2 386 | 2 659 | 3 088 |
|
EPS MXN | Released Forecast Spread | 1,41 1,58 -10.88% | 1,08 1,27 -14.83% | 2,14 2,12 0.94% | 2,37 | 2,64 | 3,17 |
| Announcement Date | 22/02/23 | 21/02/24 | 26/02/25 | - |
Quarterly results
| Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million MXN | Released Forecast Spread | 4 393 4 294 2.32% | 3 525 3 751 -6.03% | 4 197 3 644 15.18% | 4 651 4 446 4.61% | 5 093 4 710 8.11% | 4 666 4 740 -1.56% | 4 406 4 642 -5.08% |
|
EBITDA Million MXN | Released Forecast Spread | 934 906 3.09% | 732 775 -5.54% | 936 755 23.92% | 1 066 976 9.25% | 1 207 1 059 14% | 1 122 1 134 -1.09% | 1 048 1 107 -5.38% |
|
EBIT Million MXN | Released Forecast Spread | 886 869 1.96% | 664 739 -10.26% | 857 869 -1.33% | 983 920 6.9% | 1 129 1 014 11.32% | 1 013 999 1.41% | 961 1 034 -7.1% |
|
Earnings before Tax (EBT) Million MXN | Released Forecast Spread | 548 721 -23.96% | 70,6 741 -90.47% | 517 687 -24.74% | 843 746 12.99% | |||
|
Net income Million MXN | Released Forecast Spread | 371 476 -22.11% | -115 315 -136.67% | 372 343 8.58% | 632 451 40.16% | 660 511 29.27% | 473 517 -8.33% | 499 490 1.85% |
|
EPS MXN | Released Forecast Spread | 0,39 0,45 -14.12% | -0,12 0,16 -172.83% | 0,36 0,36 0.69% | 0,63 0,43 45.42% | 0,66 0,49 33.78% | 0,47 0,52 -9.62% | 0,50 0,45 11.11% |
| Announcement Date | 25/10/23 | 21/02/24 | 24/04/24 | 24/07/24 | 23/10/24 | 26/02/25 | 30/04/25 |
| 2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
| 2025-07-16 06:45 am | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
| 2025-07-16 | NOVARTIS AG: Q2 2025 Earnings Release |
| 2025-07-17 01:00 am | CAMURUS AB: Q2 2025 Earnings Release |
| 2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
| 2025-07-18 05:00 am | ORION OYJ: Q2 2025 Earnings Release |
| 2025-07-22 | DR. REDDY'S LABORATORIES LIMITED: Q1 2026 Earnings Release |
| 2025-07-22 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected) |
| 2025-07-22 | GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release |
| 2025-07-23 01:00 am | COSMO PHARMACEUTICALS N.V.: Q2 2025 Earnings Release |
Past sector events for Genomma Lab Internacional, S.A.B. de C.V.
| Today 07:51 pm | BORA PHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
| Today | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
| 2025-07-09 04:26 am | YUNGSHIN GLOBAL HOLDING CORPORATION: June 2025 Sales and Revenue Release |
| 2025-07-09 04:06 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
| 2025-07-09 01:58 am | SYNMOSA BIOPHARMA CORPORATION: June 2025 Sales and Revenue Release |
| 2025-07-02 04:08 am | ONENESS BIOTECH CO., LTD.: June 2025 Sales and Revenue Release |
| 2025-06-17 11:45 am | MEDINCELL S.A.: Q4 2025 Earnings Release |
| 2025-06-10 04:38 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
| 2025-06-10 01:42 am | CENTER LABORATORIES, INC.: May 2025 Sales and Revenue Release |
| 2025-06-10 01:37 am | SYNMOSA BIOPHARMA CORPORATION: May 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LAB B Stock
- Calendar Genomma Lab Internacional, S.A.B. de C.V.
Select your edition
All financial news and data tailored to specific country editions
